We investigated whether minimal residual disease (MRD) status in adult patients with Philadelphia chromosome (Ph)‐negative acute lymphoblastic leukemia (ALL) is useful for decision on clinical indications for allogeneic hematopoietic stem… Click to show full abstract
We investigated whether minimal residual disease (MRD) status in adult patients with Philadelphia chromosome (Ph)‐negative acute lymphoblastic leukemia (ALL) is useful for decision on clinical indications for allogeneic hematopoietic stem cell transplantation (HSCT).
               
Click one of the above tabs to view related content.